{"id":753,"date":"2026-09-01T16:45:45","date_gmt":"2026-09-01T16:45:45","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/"},"modified":"2026-09-01T16:45:45","modified_gmt":"2026-09-01T16:45:45","slug":"thymosin-alpha-1-tests-phase-3-sepsis-trial-2025","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/cn\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/","title":{"rendered":"\u8d25\u8840\u75c7\u4e2d\u7684 Thymosin Alpha-1\uff1a2025 TESTS \u9636\u6bb5 3 \u7ed3\u679c"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">2025 TESTS \u8bd5\u9a8c\u6bd4\u65e9\u671f\u7684\u5c0f\u578b\u8113\u6bd2\u75c7\u62a5\u544a\u63d0\u4f9b\u4e86\u66f4\u591a\u4fe1\u606f\uff1a1,106 \u6210\u4eba\u5728 22 \u4e2d\u5fc3\u968f\u673a\u5206\u7ec4\uff0c\u80f8\u817a\u80bd \u03b1-1 \u5e76\u672a\u964d\u4f4e 28 \u5929\u5168\u56e0\u6b7b\u4ea1\u7387\u3002<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">\u8bc1\u636e\u4e00\u76ee\u4e86\u7136<\/h2><ul class=\"wp-block-list\"><li>\u8be5\u8bd5\u9a8c\u5c06 1,106 \u6210\u4eba\u968f\u673a\u5206\u7ec4\uff1b 1,089 \u88ab\u7eb3\u5165\u4fee\u6539\u540e\u7684\u610f\u5411\u6cbb\u7597\u5206\u6790\u4e2d\u3002<\/li><li>\u80f8\u817a\u7d20 \u03b1-1 \u7ec4 28 \u5929\u6b7b\u4ea1\u7387\u4e3a 23.4%\uff0c\u5b89\u6170\u5242\u7ec4\u4e3a 24.1%\u3002<\/li><li>\u98ce\u9669\u6bd4\u4e3a0.99\uff0895% CI 0.77\u20131.27\uff1bP=0.93\uff09\uff0c\u6b21\u8981\u6216\u5b89\u5168\u6027\u7ed3\u679c\u6ca1\u6709\u663e\u7740\u5dee\u5f02\u3002<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1672\" height=\"941\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp\" alt=\"\u591a\u4e2d\u5fc3\u53cc\u81c2\u8113\u6bd2\u75c7\u8bd5\u9a8c\u6570\u636e\u53ef\u89c6\u5316\uff0c\u7ed3\u679c\u51e0\u4e4e\u91cd\u53e0\" class=\"wp-image-737\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp 1672w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence-300x169.webp 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence-1024x576.webp 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence-768x432.webp 768w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence-1536x864.webp 1536w\" sizes=\"auto, (max-width: 1672px) 100vw, 1672px\" \/><figcaption class=\"wp-element-caption\">\u539f\u59cb\u7f16\u8f91\u7814\u7a76\u63d2\u56fe\u3002\u5b83\u4e0d\u662f\u7814\u7a76\u56fe\u3001\u60a3\u8005\u56fe\u50cf\u3001\u4ea7\u54c1\u7167\u7247\u3001\u63d0\u4f9b\u7684\u5316\u9a8c\u7ed3\u679c\u6216\u76ee\u5f55\u6279\u6b21\u7684\u8868\u793a\u3002<\/figcaption><\/figure><h2 class=\"wp-block-heading\">\u5b66\u4e60\u8bb0\u5f55<\/h2><p class=\"wp-block-paragraph\">\u4e3b\u8981\u7ec8\u70b9\u662f 28 \u5929\u5185\u56e0\u4efb\u4f55\u539f\u56e0\u6b7b\u4ea1\u3002\u63a5\u8fd1\u7edf\u4e00\u7684\u98ce\u9669\u6bd4\u548c\u4ea4\u53c9\u7684\u7f6e\u4fe1\u533a\u95f4\u6ca1\u6709\u63d0\u4f9b\u603b\u4f53\u8bd5\u9a8c\u4eba\u7fa4\u6b7b\u4ea1\u7387\u964d\u4f4e\u7684\u660e\u786e\u8bc1\u636e\u3002<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>\u8bbe\u8ba1<\/strong><span>\u591a\u4e2d\u5fc3\u3001\u53cc\u76f2\u3001\u968f\u673a\u3001\u5b89\u6170\u5242\u5bf9\u7167\u9636\u6bb5 3<\/span><\/div><div class=\"pim-evidence-row\"><strong>\u7ad9\u70b9<\/strong><span>22\u4e2d\u56fd\u4e2d\u5fc3<\/span><\/div><div class=\"pim-evidence-row\"><strong>\u4fee\u6539ITT<\/strong><span>542 \u80f8\u817a\u80bd \u03b1-1\uff1b 547 \u5b89\u6170\u5242<\/span><\/div><div class=\"pim-evidence-row\"><strong>28\u65e5\u6b7b\u4ea1\u7387<\/strong><span>23.4% \u4e0e 24.1%<\/span><\/div><div class=\"pim-evidence-row\"><strong>\u6548\u679c\u9884\u4f30<\/strong><span>HR 0.99; 95% CI 0.77\u20131.27\uff1b P=0.93<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">\u4e0a\u4e0b\u6587\u4e2d\u7684\u7ed3\u679c<\/h2><p class=\"wp-block-paragraph\">\u6309\u5e74\u9f84\u548c\u7cd6\u5c3f\u75c5\u9884\u5148\u6307\u5b9a\u7684\u4e9a\u7ec4\u76f8\u4e92\u4f5c\u7528\u4ea7\u751f\u4e86\u53ef\u80fd\u7684\u5dee\u5f02\u4fe1\u53f7\u3002\u4e9a\u7ec4\u5bf9\u4e8e\u8bbe\u8ba1\u672a\u6765\u7684\u7814\u7a76\u5f88\u6709\u7528\uff0c\u4f46\u5b83\u4eec\u4e0d\u4f1a\u9006\u8f6c\u4e2d\u6027\u7684\u4e3b\u8981\u7ed3\u679c\uff0c\u4e5f\u4e0d\u5e94\u8be5\u4f5c\u4e3a\u65e2\u5b9a\u7684\u9002\u5e94\u75c7\u8fdb\u884c\u5ba3\u4f20\u3002<\/p><p class=\"wp-block-paragraph\">2025 \u835f\u8403\u5206\u6790\u6c47\u96c6\u4e86 11 \u4e0e 1,927 \u53c2\u4e0e\u8005\u7684\u968f\u673a\u8bd5\u9a8c\uff0c\u53d1\u73b0\u603b\u4f53\u4f18\u52bf\u6bd4\u4e3a 0.73\u3002\u7136\u800c\uff0c\u5176\u9ad8\u8d28\u91cf\u548c\u591a\u4e2d\u5fc3\u5b50\u96c6\u5728\u7edf\u8ba1\u4e0a\u5e76\u4e0d\u663e\u7740\uff0c\u5e76\u4e14\u8bd5\u9a8c\u5e8f\u8d2f\u5206\u6790\u5224\u65ad\u53ef\u7528\u6837\u672c\u4e0d\u8db3\u3002\u56e0\u6b64\uff0c\u5927\u7684 TESTS \u7ed3\u679c\u5c5e\u4e8e\u4efb\u4f55\u5f53\u524d\u6458\u8981\u7684\u4e2d\u5fc3\u3002<\/p><h2 class=\"wp-block-heading\">\u8bc1\u636e\u65e0\u6cd5\u8bc1\u5b9e\u4ec0\u4e48<\/h2><p class=\"wp-block-paragraph\">\u4e00\u9879\u5168\u56fd\u6027\u8bd5\u9a8c\u53ef\u80fd\u65e0\u6cd5\u4ee3\u8868\u6240\u6709\u536b\u751f\u7cfb\u7edf\u6216\u8113\u6bd2\u75c7\u8868\u578b\u3002<\/p><p class=\"wp-block-paragraph\">\u4e9a\u7ec4\u6548\u5e94\u9700\u8981\u786e\u8ba4\uff0c\u5e76\u4e14\u5e94\u8be5\u4fdd\u6301\u5047\u8bbe\u751f\u6210\u3002<\/p><p class=\"wp-block-paragraph\">\u5df2\u5b8c\u6210\u7684\u5e72\u9884\u63aa\u65bd\u7684\u4e34\u5e8a\u8bd5\u9a8c\u5e76\u4e0d\u80fd\u9a8c\u8bc1\u4e0d\u76f8\u5173\u7684\u7814\u7a76\u6279\u6b21\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>2025 TESTS \u8bd5\u9a8c\u6bd4\u65e9\u671f\u7684\u5c0f\u578b\u8113\u6bd2\u75c7\u62a5\u544a\u63d0\u4f9b\u4e86\u66f4\u591a\u4fe1\u606f\uff1a1,106 \u6210\u4eba\u5728 22 \u4e2d\u5fc3\u968f\u673a\u5206\u7ec4\uff0c\u80f8\u817a\u80bd \u03b1-1 \u5e76\u672a\u964d\u4f4e 28 \u5929\u5168\u56e0\u6b7b\u4ea1\u7387\u3002<\/p>","protected":false},"author":1,"featured_media":737,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"369","pim_article_type":"Published evidence review","pim_evidence_level":"Large multicenter randomized phase 3 human trial with a neutral primary outcome","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, study size, model\/population limits and relevant conflicts are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary\/regulatory sources, factual claims, numerical results, limitations and product-evidence boundary checked for batch 3.","pim_creation_method":"The editorial workflow began with linked PubMed primary papers, systematic reviews, PubChem identity records and FDA\/DailyMed regulatory records. Population or model, denominators, endpoints, numerical results, null findings, limitations and conflicts were extracted before drafting. AI-assisted drafting and original image generation were used; the final facts and evidence boundaries were checked against the linked records on 2026-09-02. This is not independent peer review.","pim_sources":"[{\"title\":\"TESTS phase 3 thymosin alpha-1 sepsis trial\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39814420\/\",\"note\":\"Primary 2025 multicenter trial; PMID 39814420.\"},{\"title\":\"2025 thymosin alpha-1 sepsis meta-analysis\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40969554\/\",\"note\":\"Eleven RCTs with quality and trial-sequential analyses; PMID 40969554.\"},{\"title\":\"PubChem Thymalfasin record\",\"url\":\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Thymalfasin\",\"note\":\"Sequence, formula, mass and synonym record; CID 16130571.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-753","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result<\/title>\n<meta name=\"description\" content=\"The 2025 TESTS trial is more informative than earlier small sepsis reports: 1,106 adults were randomized across 22 centers, and thymosin alpha-1 did not re\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/cn\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result\" \/>\n<meta property=\"og:description\" content=\"The 2025 TESTS trial is more informative than earlier small sepsis reports: 1,106 adults were randomized across 22 centers, and thymosin alpha-1 did not re\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/cn\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T16:45:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result\",\"datePublished\":\"2026-09-01T16:45:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/\"},\"wordCount\":272,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/thymosin-alpha1-sepsis-evidence.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/\",\"name\":\"Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/thymosin-alpha1-sepsis-evidence.webp\",\"datePublished\":\"2026-09-01T16:45:45+00:00\",\"description\":\"The 2025 TESTS trial is more informative than earlier small sepsis reports: 1,106 adults were randomized across 22 centers, and thymosin alpha-1 did not re\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/thymosin-alpha1-sepsis-evidence.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/thymosin-alpha1-sepsis-evidence.webp\",\"width\":1672,\"height\":941,\"caption\":\"AI-generated illustration: Multicenter two-arm sepsis trial data visualization with near-overlapping outcomes\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/cn\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u8d25\u8840\u75c7\u4e2d\u7684 Thymosin Alpha-1\uff1a2025 TESTS \u9636\u6bb5 3 \u7ed3\u679c","description":"2025 TESTS \u8bd5\u9a8c\u6bd4\u65e9\u671f\u7684\u5c0f\u578b\u8113\u6bd2\u75c7\u62a5\u544a\u63d0\u4f9b\u4e86\u66f4\u591a\u4fe1\u606f\uff1a1,106 \u6210\u4eba\u88ab\u968f\u673a\u5206\u914d\u5230 22 \u4e2d\u5fc3\uff0c\u80f8\u817a\u80bd \u03b1-1 \u6ca1\u6709\u91cd\u65b0\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/cn\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/","og_locale":"zh_CN","og_type":"article","og_title":"Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result","og_description":"The 2025 TESTS trial is more informative than earlier small sepsis reports: 1,106 adults were randomized across 22 centers, and thymosin alpha-1 did not re\u2026","og_url":"https:\/\/nhdbio.com\/cn\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/","og_site_name":"NHD","article_published_time":"2026-09-01T16:45:45+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u4f5c\u8005":"NHD Technical Team","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result","datePublished":"2026-09-01T16:45:45+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/"},"wordCount":272,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp","articleSection":["Published Study Reviews"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/","url":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/","name":"\u8d25\u8840\u75c7\u4e2d\u7684 Thymosin Alpha-1\uff1a2025 TESTS \u9636\u6bb5 3 \u7ed3\u679c","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp","datePublished":"2026-09-01T16:45:45+00:00","description":"2025 TESTS \u8bd5\u9a8c\u6bd4\u65e9\u671f\u7684\u5c0f\u578b\u8113\u6bd2\u75c7\u62a5\u544a\u63d0\u4f9b\u4e86\u66f4\u591a\u4fe1\u606f\uff1a1,106 \u6210\u4eba\u88ab\u968f\u673a\u5206\u914d\u5230 22 \u4e2d\u5fc3\uff0c\u80f8\u817a\u80bd \u03b1-1 \u6ca1\u6709\u91cd\u65b0\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp","width":1672,"height":941,"caption":"AI-generated illustration: Multicenter two-arm sepsis trial data visualization with near-overlapping outcomes"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"\u591a\u80bd\u539f\u6599\u4e0e\u591a\u80bd\u5b9a\u5236\u5408\u6210","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD\u6280\u672f\u56e2\u961f","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"NHD \u6280\u672f\u56e2\u961f\u7ef4\u62a4\u7814\u7a76\u7528\u9014\u76ee\u5f55\u6587\u6863\u548c\u8bc1\u636e\u6458\u8981\u3002\u7ecf\u8bc4\u5ba1\u7684\u6587\u7ae0\u94fe\u63a5\u5230\u540c\u884c\u8bc4\u5ba1\u7684\u8bba\u6587\u3001\u8bd5\u9a8c\u6ce8\u518c\u548c\u76d1\u7ba1\u8bb0\u5f55\uff0c\u4fdd\u7559\u65e0\u6548\u7ed3\u679c\u548c\u7814\u7a76\u5c40\u9650\u6027\uff0c\u5e76\u5c06\u5df2\u53d1\u8868\u7684\u5e72\u9884\u63aa\u65bd\u4e0e\u76ee\u5f55\u6750\u6599\u533a\u5206\u5f00\u6765\u3002\u7ed3\u6784\u53ef\u91c7\u7528AI\u8f85\u52a9\u7ed8\u56fe\uff1b\u6765\u6e90\u94fe\u63a5\u548c\u8bc1\u636e\u8fb9\u754c\u4ecd\u7136\u53ef\u89c1\u3002\u8fd9\u9879\u5de5\u4f5c\u4e0d\u662f\u72ec\u7acb\u7684\u540c\u884c\u8bc4\u5ba1\u6216\u533b\u7597\u5efa\u8bae\u3002","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/cn\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/posts\/753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/comments?post=753"}],"version-history":[{"count":0,"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/posts\/753\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/media\/737"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/media?parent=753"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/categories?post=753"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/cn\/wp-json\/wp\/v2\/tags?post=753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}